Samsung Next

Corporate VC Mountain View, United States · Founded 2013

Samsung Next invests in early-stage startups developing software, hardware, and services that deliver higher quality experiences and better outcomes at lower costs, with a strong emphasis on non-clinical healthtech, AI, and consumer services.

About Samsung Next

Samsung Next is the venture and innovation arm of Samsung focused on consumer software, AI, and digital platforms, including selectively digital health, mental health, and consumer wellness products that align with Samsung’s device and platform strategy. Stage focus is seed through Series B, with checks plausibly in the $1M to $10M range depending on stage. Healthcare exposure is opportunistic and concentrated in consumer-facing digital health, mental health, and wellness platforms rather than therapeutics, devices, or hospital-side enterprise software. Physician founders building consumer mental health platforms, wellness apps with credible engagement and retention signals, or digital health products with Samsung device or platform alignment are the right profile. Founders building therapeutics, B2B hospital software, or capital-intensive devices should pitch elsewhere. Geographic posture is global, with active deal capacity in North America, Europe, and Israel. The realistic entry path is a warm introduction from a Samsung Next portfolio CEO, a co-investing seed or Series A fund, or a Samsung product team contact; the partners are responsive and the process is generally founder-friendly. Founders should arrive with consumer-grade engagement metrics, retention math, and an articulated product narrative. Treat Samsung Next as a strategic consumer-tech partner with platform distribution insight, particularly relevant for digital health founders building consumer-pull products that align with the broader Samsung ecosystem.

Founder reviews

No founder reviews yet. Raised from this fund? Share your experience with other founders.

Healthcare AI tools backed by Samsung Next

Tools made by companies in Samsung Next's portfolio that we cover in the directory.

DIP/U.S. Urine Analysis Test System
Healthy.io
Lab & Diagnostics
Healthy.io's smartphone-powered AI urine analysis system enables clinical-grade, at-home testing for conditions like kidney disease and UTIs, leveraging computer vision and artificial intelligence.
Minuteful-kidney test
Healthy.io
Lab & Diagnostics
Healthy.io's Minuteful Kidney test is an FDA-cleared, smartphone-powered home urine test that uses AI and computer vision to detect early signs of Chronic Kidney Disease (CKD) by measuring albumin-creatinine ratio (ACR) and securely sending results to healthcare providers.
ACR LAB Urine Analysis Test
Healthy.io
Endocrinology & Metabolic AI
Healthy.io's ACR LAB Urine Analysis Test System uses AI and smartphone technology for semi-quantitative detection of albumin and creatinine in urine, providing clinical-grade results for kidney function assessment at the point of care.
K Health
K Health
Patient Intake & Forms
K Health offers an AI-powered symptom checker and virtual primary care, serving as a digital triage tool for patients and health systems, integrating with top health systems to provide 24/7 comprehensive primary care at a lower cost.
Daylight
Big Health
Mental & Behavioral Health AI
Daylight is a digital care program for worry and anxiety—available anytime, anywhere. It offers tailored support and helps users track their progress with day-to-day practices and techniques for meaningful behavior change.
Atropos Health
Atropos Health
Clinical Decision Support & Reference
Atropos Health creates high-quality personalized Real-World Evidence in minutes and at scale, creating the trusted currency of value in healthcare. Atropos Health is the industry leader in producing novel, methodologically credible RWE-reports with unprecedented quality and speed, fueled by our mission to improve healthcare outcomes for everyone.
PatientGPT
K Health
Patient Engagement & Education
PatientGPT is a clinical AI tool from K Health that integrates with EHRs and patient portals to provide personalized health information and connect patients with care teams, grounded in their individual medical records.

Portfolio companies in our directory

Other portfolio companies

Companies in Samsung Next's portfolio not currently in our directory.

Team

David Lee
Head of Samsung Next
Raymond Liao
Managing Director
Andy Duong
Investment Director

Pitch / review this investor

Have you raised from Samsung Next? Founders only — share your honest experience (anonymous OK, moderated before publishing).

Share your experience
Last updated 2026-05-06. Sourced from this fund's published materials.
AI Tool Finder
AI-powered search. Results may not be comprehensive.